Who owns NEUROBO PHARMACEUTICALS INC?
- Ticker: MTVA
- CUSIP Number: 64132r404
Tip: Access positions for across all investors
Analyze quarterly positions in Neurobo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurobo Pharmaceuticals stock
Who bought or sold NEUROBO PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 153k | $144k | 141% | Sep 2025 |
|
| Geode Capital Management | 70k | $66k | 96% | Sep 2025 |
|
| SG Americas Securities | 60k | $57k | 44% | Sep 2025 |
|
| Jane Street | 52k | $49k | 100% | Sep 2025 |
|
| Two Sigma Securities | 39k | $36k | 100% | Sep 2025 |
|
| Virtu Financial | 33k | $31k | 100% | Sep 2025 |
|
| State Street Corporation | 16k | $15k | 0% | Sep 2025 |
|
| Northern Trust | 14k | $13k | 0% | Sep 2025 |
|
| Tower Research Capital | 7.9k | $7.5k | 94% | Sep 2025 |
|
| BlackRock | 5.3k | $5.0k | 0% | Sep 2025 |
|
| SBI Securities | 923.00 | $867.989200 | 252% | Sep 2025 |
|
| UBS Group | 692.00 | $649.995600 | -99% | Sep 2025 |
|
| Brown Brothers Harriman & Co. | 27.00 | $24.999300 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 4.00 | $4.000000 | 0% | Sep 2025 |
|
Who sold out of Neurobo Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2025 | 17k | $11k |
| Ground Swell Capital | Jun 2025 | 11k | $6.8k |
| Mount Yale Investment Advisors | Jun 2025 | 276.00 | $177.992400 |
| Jpmorgan Chase & Co | Mar 2025 | 6.00 | $9.000000 |